capecitabine or 5-FU + Intensity Modulated Radiation Therapy (IMRT) + DOSTARLIMAB for endometrial neoplasms

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 18 Nov 2019: Trial registered, NCT04165772
  2. 11 Dec 2019: Trial started, NCT04165772

The trials

NCT04165772: Study of Induction PD-1 Blockade in Subjects With Locally Advanced Mismatch Repair Deficient Solid Tumors

State
Under way
Phase
Phase 2
People
212 planned
Started
11 Dec 2019
Primary completion
30 Nov 2026
Arms
Cohort 1
Results
None posted
  1. 18 Nov 2019: Trial registered
  2. 11 Dec 2019: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.